BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25757477)

  • 1. Results of surgical resection after induction chemoradiation for Pancoast tumours †.
    Marulli G; Battistella L; Perissinotto E; Breda C; Favaretto AG; Pasello G; Zuin A; Loreggian L; Schiavon M; Rea F
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):805-11; discussion 811-2. PubMed ID: 25757477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined treatment modalities in Pancoast tumor: results of a monocentric retrospective study.
    Jeannin G; Merle P; Janicot H; Thibonnier L; Kwiatkowski F; Naame A; Chadeyras JB; Galvaing G; Belliere A; Filaire M; Verrelle P
    Chin Clin Oncol; 2015 Dec; 4(4):39. PubMed ID: 26730751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes and prognostic factors of non-small-cell lung cancer with lymph node involvement treated with induction treatment and surgical resection.
    Marulli G; Verderi E; Zuin A; Schiavon M; Battistella L; Perissinotto E; Romanello P; Favaretto AG; Pasello G; Rea F
    Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):256-62; discussion 262. PubMed ID: 24824495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction chemotherapy, concurrent chemoradiation and surgery for Pancoast tumour.
    Marra A; Eberhardt W; Pöttgen C; Theegarten D; Korfee S; Gauler T; Stuschke M; Stamatis G
    Eur Respir J; 2007 Jan; 29(1):117-26. PubMed ID: 16971407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of combined modality treatment in patients with non-small-cell lung cancer of the superior sulcus and the rationale for surgical resection.
    Kappers I; van Sandick JW; Burgers JA; Belderbos JS; Wouters MW; van Zandwijk N; Klomp HM
    Eur J Cardiothorac Surg; 2009 Oct; 36(4):741-6. PubMed ID: 19699647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome after en bloc resection of non-small-cell lung cancer invading the pulmonary sulcus and spine.
    Collaud S; Waddell TK; Yasufuku K; Pierre AF; Darling GE; Cypel M; Rampersaud YR; Lewis SJ; Shepherd FA; Leighl NB; Cho J; Bezjak A; Tsao MS; Keshavjee S; de Perrot M
    J Thorac Oncol; 2013 Dec; 8(12):1538-44. PubMed ID: 24389435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
    Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
    Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative analysis of Pancoast tumour resection performed via video-assisted thoracic surgery versus standard open approaches.
    Caronia FP; Fiorelli A; Ruffini E; Nicolosi M; Santini M; Lo Monte AI
    Interact Cardiovasc Thorac Surg; 2014 Sep; 19(3):426-35. PubMed ID: 25052071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent cisplatin/etoposide plus 3D-conformal radiotherapy followed by surgery for stage IIB (superior sulcus T3N0)/III non-small cell lung cancer yields a high rate of pathological complete response.
    Pourel N; Santelmo N; Naafa N; Serre A; Hilgers W; Mineur L; Molinari N; Reboul F
    Eur J Cardiothorac Surg; 2008 May; 33(5):829-36. PubMed ID: 18367406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trimodality therapy for Pancoast tumors: T4 is not a contraindication to radical surgery.
    Waseda R; Klikovits T; Hoda MA; Hoetzenecker K; Bertoglio P; Dieckmann K; Zöchbauer-Müller S; Pirker R; Prosch H; Döme B; Klepetko W
    J Surg Oncol; 2017 Aug; 116(2):227-235. PubMed ID: 28407246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoradiation Therapy Followed by Surgery in the Treatment of Locoregionally Advanced Non-Small Cell Lung Cancer.
    Cohen C; Pop D; Venissac N; Poudenx M; Otto J; Castelnau O; Mouroux J
    Thorac Cardiovasc Surg; 2018 Mar; 66(2):129-134. PubMed ID: 28992652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Outcome of surgical treatment for Pancoast lung carcinoma in Iceland].
    Fridriksson BM; Jónsson S; Oskarsdottir GN; Orrason AW; Ísaksson HJ; Gudbjartsson T
    Laeknabladid; 2015 Jul; 101(7-8):351-5. PubMed ID: 26158627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of a trimodality regimen for stage III non-small-cell lung cancer using chemotherapy as induction treatment with concurrent hyperfractionated chemoradiation with carboplatin and paclitaxel followed by subsequent resection: a single-center study.
    Friedel G; Budach W; Dippon J; Spengler W; Eschmann SM; Pfannenberg C; Al-Kamash F; Walles T; Aebert H; Kyriss T; Veit S; Kimmich M; Bamberg M; Kohlhaeufl M; Steger V; Hehr T
    J Clin Oncol; 2010 Feb; 28(6):942-8. PubMed ID: 20100967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose radiotherapy in trimodality treatment of Pancoast tumors results in high pathologic complete response rates and excellent long-term survival.
    Kwong KF; Edelman MJ; Suntharalingam M; Cooper LB; Gamliel Z; Burrows W; Hausner P; Doyle LA; Krasna MJ
    J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1250-7. PubMed ID: 15942564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
    Sonett JR; Suntharalingam M; Edelman MJ; Patel AB; Gamliel Z; Doyle A; Hausner P; Krasna M
    Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of surgery in a multidisciplinary approach to superior sulcus tumors (SST): morbidity and prognostic factors for long-term success after resection.
    Torre W; Garcia-Franco C; Tamura A; Gurpide A; Lopez-Picazo J; Aristu J; Moreno M; Pardo J
    Thorac Cardiovasc Surg; 2009 Sep; 57(6):353-7. PubMed ID: 19707978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trimodality therapy for superior sulcus tumours: evolution and evaluation of a treatment protocol.
    Vos CG; Hartemink KJ; Blaauwgeers JL; Oosterhuis JW; Senan S; Smit EF; Thunnissen E; Paul MA
    Eur J Surg Oncol; 2013 Feb; 39(2):197-203. PubMed ID: 23062624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical Treatment of Superior Sulcus Tumors: A 15-Year Single-center Experience.
    Solli P; Casiraghi M; Brambilla D; Maisonneuve P; Spaggiari L
    Semin Thorac Cardiovasc Surg; 2017 Spring; 29(1):79-88. PubMed ID: 28684003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant chemoradiotherapy after curative resection for extrahepatic bile duct cancer: a long-term single center experience.
    Kim K; Chie EK; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
    Am J Clin Oncol; 2012 Apr; 35(2):136-40. PubMed ID: 21325937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.